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ABSTRACT: Passive sampling is proposed as an alternative to
traditional grab- and composite-sampling modes. Investigated here is a
novel passive sampler conﬁguration, the Chemcatcher containing an
Atlantic HLB disk covered by a 0.2 μm poly(ether sulfone) membrane,
for monitoring polar organic micropollutants (personal care products,
pharmaceuticals, and illicit drugs) in wastewater eﬄuent. In situ
calibration showed linear uptake for the majority of detected
micropollutants over 9 days of deployment. Sampling rates (RS) were
determined for 59 compounds and were generally in the range of 0.01−
0.10 L day−1. The Chemcatcher was also suitable for collecting chiral
micropollutants and maintaining their enantiomeric distribution during
deployment. This is essential for their future use in developing more
accurate environmental risk assessments at the enantiomeric level.
Application of calibration data in a subsequent monitoring study showed
that the concentration estimated for 92% of micropollutants was within a factor of 2 of the known concentration. However, their
application in a legislative context will require further understanding of the properties and mechanisms controlling
micropollutant uptake to improve the accuracy of reported concentrations.
1. INTRODUCTION
The presence of polar organic micropollutants (e.g., personal
care products, pharmaceuticals, and illicit drugs) in the aquatic
environment is of concern due to their unknown long-term
eﬀects on aquatic life and on human health. Their concentrations
have been reported in U.K. surface waters ranging from low ng
L−1 levels up to ∼10 μg L−1.1 The main route of entry into the
environment for these micropollutants is from the discharge of
eﬄuent from wastewater treatment works (WwTWs). Con-
sequently, monitoring wastewater eﬄuent for micropollutants is
essential to assess the possible risk to the receiving environment.
Traditionally, active sampling has been used to monitor polar
organic micropollutants in wastewater and surface water.2 This
includes grab or spot sampling as well as a 24 h composite
sampling (time-, volume-, or ﬂow-proportional). However,
passive samplers are proposed as a lower-cost, easy-to-use
alternative.3−6 Passive sampling relies on the transport of
micropollutant from the sampled matrix to a receiving phase
within a sampling device. This is a result of the diﬀerence
between chemical potentials of the micropollutant in the two
types of media.7 Chemical potential in this case is the diﬀerence
in the physicochemical properties of the micropollutants under
investigation and the resultant movement by absorption or
adsorption of compounds from an unfavorable (bulk-water
phase) to a more favorable medium (receiving phase). Passive
samplers can be used to estimate time-weighted average
concentrations for comparatively long time periods (≥7 days).
However, for this to be successful, sampling rates (RS) of each
micropollutant must be known for the sampler applied. This has
limited the use of passive sampling for quantitative analysis
because RS derived in the laboratory (typically using clean water
spiked with the micropollutants under investigation) do not
represent what is observed in the ﬁeld.3
In situ calibration is recommended for determining
representative RS because it can be conducted in the exact
location where future measurements are to be taken.8 Relative to
laboratory calibrations, very few in situ calibrations have been
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performed for polar organic micropollutants in aquatic
matrices,3−6 mainly due to the considerable amount of eﬀort
they demand. However, this approach is considered essential for
quantitative purposes because it accounts for site-speciﬁc factors
(e.g., matrix composition) that cannot be adequately replicated
under laboratory conditions. Once calibrated in situ, the
determined RS can be applied to estimate micropollutant
concentrations in future studies at the same site. In situ
calibration oﬀers other advantages as an extensive experimental
laboratory setup need not be required and maintained.8
Moreover, it avoids the need to purchase relatively large
quantities of target micropollutants for laboratory experiments,
which may be cost-prohibitive.9
There is also debate whether or not RS can be predicted for
polar organic micropollutants using physicochemical properties.
Ideally, RS could be determined on the basis of micropollutant-
speciﬁc properties such as log KOW or logDOW.
6 This could avoid
the requirement to undertake future calibration studies. To date,
this has not been possible for polar organic micropollutants,
partly due to the lack of ﬁeld-derived RS available for a high-
enough number of compounds using a standardized sampling
approach. Nevertheless, Moschet et al.6 did report a weak
relationship (r2 = 0.37) between ﬁeld RS (river water) and log
DOW for 88 micropollutants.
Another emerging area of environmental research is chirality.
Approximately half of all drugs are chiral and exist as two or more
enantiomers.10 These tend to be dispensed as racemic mixtures
(equimolar concentrations of each enantiomer). However, they
are subject to stereoselective mechanisms within the human
body and during wastewater treatment. Consequently, enrich-
ment of one enantiomer is normally observed in wastewater
eﬄuent and in the environment. This is signiﬁcant because
enantiospeciﬁc toxicity is observed for some chiral micro-
pollutants.11−13 Reporting chiral micropollutants at the enantio-
meric level is essential for developing more-accurate environ-
mental risk assessments. To date, passive samplers have not been
assessed for their ability to describe the enantiomeric distribution
of chiral micropollutants. Due to their length of deployment, it is
possible that stereoselective changes in chiral micropollutant
composition could occur.
There are two general passive sampler conﬁgurations available
for monitoring polar organic micropollutants: the polar organic
compound integrative sampler (POCIS) containing Oasis
hydrophilic−lipophilic balance (HLB) as a loose powder, and
the Chemcatcher, typically containing a styrenedivinylbenzene
adsorbent bound in a PTFE matrix disk.6 The exposed surface of
the sorbent is normally covered with a thin poly(ether sulfone)
(PES) membrane. Using the HLB sorbent is an obvious choice
for the receiving material because it is the preferred sorbent for
analytical methods involving extracting a broad range of polar
organic micropollutants in grab or composite water sam-
ples.14−16 This has been demonstrated in numerous previous
studies using POCIS (≥21), with >90 individual pharmaceuticals
detected.8 However, the Chemcatcher conﬁguration is easier to
use and handle. Using the Chemcatcher with a HLB receiving
phase is desirable because it combines the proven ability of HLB
as a sorbent for a broad range of polar organic micropollutants
with the handling beneﬁts of the Chemcatcher. This study
investigated the use of the Chemcatcher containing an Atlantic
HLB disk in wastewater eﬄuent for the ﬁrst time. To help
address the suitability of this sampler conﬁguration for
monitoring polar organic micropollutants in wastewater eﬄuent,
the objectives of this study were to:
(i) assess the Chemcatcher containing an Atlantic HLB disk
for the uptake of a broad range of polar organic
micropollutants and to determine their ﬁeld RS in
wastewater eﬄuent by in situ calibration;
(ii) investigate whether log KOW or log DOW can be used as a
reasonable predictor of ﬁeld RS in wastewater eﬄuent;
(iii) measure the accuracy of micropollutant concentrations
determined in a future study using the ﬁeld calibration
data; and
(iv) establish the suitability of the Chemcatcher for describing
the enantiomeric distribution of chiral micropollutants.
This was achieved by deploying Chemcatcher samplers in
eﬄuent wastewater of a trickling ﬁlter WwTW in southwest
England while simultaneously undertaking 24 h composite
sampling. A total of 88 micropollutants were investigated using a
fully quantitative ultraperformance liquid chromatography
tandem mass spectrometry (UPLC−MS/MS) method. Enantio-
selective analysis was also performed to determine the
enantiomeric distribution of selected chiral micropollutants.
2. MATERIALS AND METHODS
2.1. Materials. Information on 88 micropollutants studied
are detailed in Table S1. These are representative of highly
prescribed pharmaceuticals, over-the-counter medications,
known endocrine disruptors, and illicit drugs.1 The internal
standards acetaminophen-D4, ibuprofen-D3, bisphenol A-D16,
carbamazepine-13C6, ketoprofen-D3, naproxen-D3, sertraline-
D3, tamoxifen-13C2−15N, propranolol-D7, atenolol-D5, and
metformin (dimethyl-D6) were purchased from Sigma-Aldrich
(Gillingham, UK). Bezaﬁbrate-D6 was obtained from QMX
laboratories (Thaxted, UK). Methylparaben-13C, amphetamine-
D5, methamphetamine-D5, 3,4-methylenedioxy-methamphet-
amine-D5 (MDMA-D5), 3,4-methylenedioxy-amphetamine-D5
(MDA-D5), heroin-D9, codeine-D6, ketamine-D4, cocaine-D3,
benzoylecgonine-D8, 2-ethylidene-1,5-dimethyl-3,3-diphenyl-
pyrrolidine-D3 (EDDP-D3), morphine-D3, cotinine-D3, coca-
ethylene-D8, temazepam-D5, 1S,2R-(+) ephedrine-D3, mephe-
drone-D3, methadone-D9, norketamine-D4, estrone (2,4,16,16-
D4), estradiol (2,4,16,16-D4), and quetiapine-D8 hemifumurate
were purchased from LGC standards (Middlesex, UK).
Citalopram-D6, metoprolol-D7, ﬂuoxetine-D5, and mirtaza-
pine-D3 were obtained from TRC (Toronto, Canada).
Methanol (MeOH) and toluene were HPLC-grade and
purchased from Sigma-Aldrich. Water (H2O) was of 18.2 MΩ
quality (Elga, Marlow, UK). Glassware was deactivated using 5%
dimethylchlorosilane in toluene (Sigma-Aldrich) to mitigate the
loss of basic chemicals onto −OH sites present on glass surfaces.
Ammonium acetate (NH4OAc), ammonium ﬂuoride (NH4F),
and acetic acid (CH3COOH, 1.0 M) used in the preparation of
mobile phases were purchased from Sigma-Aldrich. Oasis HLB
(60 mg, 3 mL) solid-phase extraction (SPE) cartridges were
purchased from Waters (Manchester, UK). Whatman GF/F
glass ﬁber membranes (0.7 μm) were obtained from Sigma-
Aldrich. Atlantic HLB−L disks (47 mm) containing Oasis HLB
sorbent were purchased from ARC Sciences (Alton, UK). Supor
poly(ether sulfone) (PES) 0.2 μm membrane ﬁlters (90 mm)
were obtained from Sigma-Aldrich. These were cut to 49 mm
circles using a wad punch (KS Tools, Heusenstamm, Germany).
The Chemcatcher samplers comprised three PTFE components;
the main body, a retaining screw to hold the 47 mm receiving-
phase disk in place, and a protective cover for transport (see
Figure S1).
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2.2. Analytical Methods. 2.2.1. Extraction of Composite
Samples. Liquid samples were ﬁltered through 0.7 μm glass ﬁber
membranes and 50mL aliquots spiked with 50 ng of all surrogate
and internal standards. These were loaded onto preconditioned
Oasis HLB cartridges (2 mL of MeOH and 2 mL of H2O) at 5
mL min−1, dried under a vacuum, and eluted under gravity using
MeOH (4mL). Extracts were then dried under nitrogen at 40 °C
and reconstituted in 500 μL of H2O/MeOH (80:20 v/v).
Samples for analysis by direct injection (400 μL) were spiked
with 50 ng of selected surrogate snf internal standards and
adjusted to 500 μL with MeOH.15
2.2.2. Preparation and Extraction of Atlantic HLB Disks.
Atlantic HLB disks were conditioned with MeOH (50 mL)
followed by H2O (50 mL) and then dried. These were then
placed on the Chemcatcher body, a precleaned PES membrane
was placed on top, and the retaining ring was screwed on. These
were then stored at 4 °C for a maximum of 12 h until
deployment. After deployment, collected samples were dried
under vacuum and frozen until extraction. Disks were then
brought to room temperature, extracted under gravity using
MeOH (40 mL), and spiked with 50 ng of all surrogate and
internal standards. Extracts were then evaporated to dryness
using a “Rocket” centrifugal rotary evaporator (Genevac,
Ipswich, UK) set at 40 °C. Samples were then reconstituted in
500 μL of H2O/MeOH (80:20 v/v) prior to LC−MS/MS
analysis.
2.2.3. LC−MS/MS Analysis. All samples were analyzed using a
fully validated UPLC−MS/MS method.15 A Waters Acquity
UPLC system (Manchester, UK) coupled to a Xevo TQDTriple
Quadrupole mass spectrometer (Waters) was used. A total of
two chromatography methods using a reverse-phase BEH C18
column (150 × 1.0 mm, 1.7 μm particle size) (Waters) with a 0.2
μm, 2.1 mm in-line column ﬁlter maintained at 25 °C were used.
Acidic micropollutants were separated using a methanol−water
gradient containing 1 mMNH4F and basic micropollutants using
5 mM NH4OAc and 3 mM CH3COOH. A total of two MS/MS
transitions were monitored (when possible) for quantitation and
conﬁrmation purposes (see Table S2). Standard tolerances of ion
ratio and chromatographic retention time were also employed to
ensure the quality of reported data (see Table S3).17 A full
description of the method is available in Petrie et al.15
For the enantioselective separation of chiral micropollutants, a
cellobiohydrolase (CBH) column (100 × 2 mm, 5 μm internal
diameter) and a mobile phase consisting of 1 mM NH4OAc in
H2O/MeOH (85:15 v/v) was used. A full description of the
method is available in Castrignano ̀ et al.16 (see Table S3).
Enantiomeric distribution of chiral micropollutants was ex-
pressed as enantiomeric fraction (EF), which was calculated
according to eq 1:
= +
+ + −
E
E E
EF
( )
[ ( ) ( )] (1)
where EF is the enantiomeric fraction, E(+) is the peak area of
the (+) enantiomer corrected for the deuterated internal
standard response, and E(−) is the peak area of the (−)
enantiomer corrected for the deuterated internal standard
response. An EF of 0.5 denotes a racemic mixture.
2.3. Wastewater Properties.During all studies, wastewater
properties including temperature, pH, total organic carbon
(TOC), and dissolved organic carbon (DOC, ﬁltered through
0.7 μm glass ﬁber membranes) content as well as suspended
solids concentration were monitored. TOC and DOC were
measured using a TOC-VCPN Total Organic Carbon Analyzer
TOC-VCPN (Shimadzu, Milton Keynes, UK). Suspended solids
concentration was determined using standard methods.18
2.4. Calibration and Monitoring Studies. The WwTW
used in the study was located in an area of southwest England
with a population equivalent of 105 847. The process consists of
primary screens and grit removal followed by conventional
primary sedimentation, trickling ﬁlters, and ﬁnal sedimentation
in humus tanks. All sampling was conducted in a ﬁnal eﬄuent
chamber that receives the whole ﬂow of the WwTW. The
eﬄuent, on leaving this chamber, passes over a weir ensuring that
it remained at the same level throughout the day, irrespective of
any variation in ﬂow. This ensured Chemcatcher samplers
remained completely submerged throughout their deployment.
For the calibration study (January 19, 2015), 30 samplers were
ﬁxed onto a lightweight metal frame (54 cm× 42 cm) using cable
ties and lowered into the chamber (see Figure S2). The frame
was tethered using chains, leaving the samplers submerged at a
depth of approximately 1 m. Chemcatchers were removed in
triplicate at times of 0.3, 1, 2, 3, 4, 5, 6, 7, 8, and 9 days. Samplers
were deployed on a Monday. Upon collection, they were
transported to the laboratory on ice within 30 min. These were
dried and frozen at −20 °C. During the calibration study, 24 h
time composites were collected simultaneously for days 1 to 8
using an ISCO 3700 portable sampler (RS Hydro, Worcester-
shire, UK). Subsamples were collected every 15min over the 24 h
time period and cooled to 4 °C.19 All subsamples were mixed on
collection and transported to the laboratory on ice.
The accumulation of micropollutants in the passive sampler
can be described by a ﬁrst-order, one-compartment mathemat-
ical model.7 An initial linear uptake phase is followed by curve−
linear and equilibrium phases. The overall accumulation of a
micropollutant in the passive sampler can be described using eq
2:
= − −C C K [1 e ]ktS W PW (2)
Here, CS is the accumulated mass of a given micropollutant in the
passive sampler, CW is concentration of the micropollutant in
eﬄuent wastewater, KPW is the passive sampler-water partition
coeﬃcient of a given micropollutant, k is oﬄoad rate constant of
the micropollutant from the passive sampler, and t is the
deployment time.
In the linear-uptake phase, sampling rates (RS) are derived
from the slope of the regression between the mass of
micropollutant accumulated on the passive disk against the
concentration in eﬄuent wastewater determined from time-
composite samples versus deployment time.7 To calculate RS, the
average eﬄuent concentration was used for that time period. For
example, on day 5, the average eﬄuent concentration from days 1
to 5 was used, and so on. Here, the sorbent is assumed to act as an
inﬁnite sink for micropollutants, and Cw can be calculated using
eq 3:
=C C
R tW
S
S (3)
In the equilibrium phase, where exposure time has been suﬃcient
to reach equilibrium with the receiving phase, CW can be
calculated according to eq 4:
=C C
K MW
S
PW S (4)
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Table 1. Mean Eﬄuent Wastewater Concentration and Regression Information from the in Situ Calibration Studya
linearity
micropollutant class micropollutant
effluent wastewater (n =
8, ng L−1)
range
(day) r2 comments
RS (L
d−1)
log
Kpw
UV filters benzophenone-1 <MQL − − <MQL in composites − −
benzophenone-2 <MQL − − <MQL in composites and passive
disks
− −
benzophenone-3 157 ± 20.7 2−8 0.957 linear 0.011 −
benzophenone-4 2419 ± 251 1−8 0.970 linear 0.049 −
parabens methylparaben 23.7 ± 6.0 1−8 0.954 linear 0.055 −
ethylparaben 6.8 ± 1.2 − − nonlinear − 3.03
propylparaben 11.1 ± 5.7 2−8 0.947 linear 0.068 −
butylparaben <MQL − − <MQL in composites and passive
disks
− −
plasticizer bisphenol-A 120 ± 27.3 1−8 0.995 linear 0.031 −
steroid estrogens E1 24.4 ± 2.4 2−8 0.996 linear 0.071 −
E2 <MQL − − <MQL in composites and passive
disks
− −
EE2 <MQL − − <MQL in composites and passive
disks
− −
antibacterials and
antibiotics
sulfasalazine 68.3 ± 6.1 1−8 0.996 linear 0.154 −
clarithromycin 1962 ± 452 1−8 0.939 linear 0.024 −
azithromycin 143 ± 18.6 1−8 0.987 linear 0.024 −
trimethoprim 1041 ± 123 1−8 0.992 linear 0.028 −
sulfamethoxazole 147 ± 68.4 1−8 0.946 linear 0.058 −
hypertension valsartan 266 ± 34.8 1−8 0.992 linear 0.060 −
irbesartan 77.0 ± 19.9 1−8 0.994 linear 0.087 −
lisinopril 198 ± 22.2 1−8 0.976 linear 0.059 −
NSAIDs ketoprofen 51.3 ± 10.0 1−8 0.991 linear 0.037 −
ibuprofen 2838 ± 347 1−8 0.988 linear 0.048 −
naproxen 5202 ± 515 1−8 0.992 linear 0.048 −
diclofenac 411 ± 82.5 1−8 0.993 linear 0.044 −
acetaminophen 940 ± 276 − − nonlinear − 3.08
lipid regulators bezafibrate 811 ± 62.4 1−8 0.997 linear 0.042 −
atorvastatin 115 ± 32.9 1−8 0.976 linear 0.013 −
antihistamines fexofenadine 610 ± 62.1 1−8 0.997 linear 0.059 −
cetirizine 403 ± 39.6 1−8 0.976 linear 0.039 −
diabetes metformin 25 845 ± 2255 − − nonlinear − 1.94
gliclazide 61.7 ± 9.9 1−8 0.991 linear 0.045 −
cough suppressant pholcodine <MQL − − <MQL in composites and passive
disks
− −
β-blocker atenolol 830 ± 51.7 1−8 0.985 linear 0.034 −
metoprolol 18.2 ± 2.9 1−8 0.980 linear 0.050 −
propranolol 90.2 ± 10.0 1−8 0.995 linear 0.114 −
H2 receptor agonists ranitidine 1438 ± 331 1−7 0.944 linear 0.043 −
cimetidine 54.0 ± 10.6 1−7 0.992 linear 0.085 −
x-ray contrast media iopromide <MQL − − <MQL in composites and passive
disks
− −
drug precursor and
metabolite
ephedrine/pseudoephedrine 220 ± 27.7 1−8 0.995 linear 0.044 −
norephedrine <MQL − − <MQL in composites and passive
disks
− −
anticancer azathioprine <MQL − − <MQL in composites and passive
disks
− −
methotrexate <MQL − − <MQL in composites and passive
disks
− −
ifosfamide <MQL − − <MQL in composites and passive
disks
− −
tamoxifen <MQL − − <MQL in composites and passive
disks
− −
anesthetic and metabolite ketamine <MQL − − <MQL in composites − −
norketamine <MQL − − <MQL in composites and passive
disks
− −
antidepressants and
metabolites
venlafaxine 235.0 ± 13.9 1−8 0.993 linear 0.065 −
fluoxetine 38.3 ± 5.9 1−8 0.978 linear 0.032 −
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Here, MS is mass of sorbent per sampler, and KPW can be
calculated by rearranging eq 4.
To determine the robustness of the derived calibration data, a
monitoring study was undertaken during June of 2015. Here,
seven Chemcatchers were deployed for 7 days. Over these 7 days,
24 h time composite water samples were also collected in the
same way as that described above. In this case, sampling ran from
Wednesday to Tuesday. Field blanks were also analyzed during
the calibration and monitoring studies, with no micropollutants
found to be quantiﬁable.
Table 1. continued
linearity
micropollutant class micropollutant
effluent wastewater (n =
8, ng L−1)
range
(day) r2 comments
RS (L
d−1)
log
Kpw
norfluoxetine 29.5 ± 0.9 − − no linearity established
(concentration too low)
− −
sertraline 22.0 ± 2.7 1−8 0.988 linear 0.116 −
mirtazapine 36.7 ± 2.9 1−8 0.997 linear 0.074 −
citalopram 244 ± 18.2 1−8 0.996 linear 0.069 −
desmethylcitalopram 47.1 ± 6.7 1−8 0.988 linear 0.149 −
antiepileptic and
metabolites
carbamazepine 196 ± 14.8 1−8 0.995 linear 0.045 −
carbamazepine 10,11-epoxide <MQL − − <MQL in composites and passive
disks
− −
10,11-dihydro-10-
hydroxycarbamazepine
55.5 ± 9.8 1−8 0.990 linear 0.077 −
calcium channel blocker diltiazem 24.4 ± 8.8 3−8 0.895 linear 0.185 −
hypnotic temazepam 21.6 ± 4.2 1−8 0.988 linear 0.326 −
antipsychotic quetiapine 7.9 ± 2.0 2−8 0.989 linear 0.107 −
veterinary tylosin <MQL − − <MQL in composites and passive
disks
− −
human indicators and
metabolites
creatinine 12 682 ± 3975 − − <MQL in passive disks − −
nicotine 136 ± 28.0 1−8 0.961 linear 0.234 −
caffeine 7453 ± 1015 1−8 0.993 linear 0.037 −
cotinine 551 ± 42.3 1−8 0.992 linear 0.041 −
1,7-dimethylxantine 10 287 ± 1180 1−8 0.997 linear 0.052 −
analgaesics and
metabolites
morphine 460 ± 72.5 1−8 0.981 linear 0.031 −
dihydromorphine <MQL − − <MQL in composites − −
normorphine 38.9 ± 10.5 2−8 0.954 linear 0.056 −
methadone 9.4 ± 2.7 1−8 0.976 linear 0.226 −
EDDP 66.5 ± 4.5 1−8 0.985 linear 0.056 −
codeine 1137 ± 96.3 1−8 0.979 linear 0.056 −
norcodeine 117.3 ± 9.3 1−8 0.972 linear 0.052 −
dihydrocodeine 257.5 ± 21.8 1−8 0.979 linear 0.047 −
tramadol 683 ± 57.2 1−8 0.985 linear 0.047 −
N-desmethyltramadol 134 ± 14.9 1−8 0.984 linear 0.087 −
O-desmethyltramadol 572 ± 58.9 1−8 0.954 linear 0.023 −
stimulants and
metabolites
amphetamine 111 ± 55.7 1−8 0.968 linear 0.028 −
methamphetamine 4.9 ± 0.6 1−8 0.947 linear 0.025 −
MDMA 109 ± 95 1−8 0.986 linear 0.074 −
MDA 15.5 ± 14.2 − − no linearity established
(concentration too low)
− −
cocaine 114.7 ± 43.6 1−8 0.991 linear 0.061 −
benzoylecgonine 518 ± 193 1−8 0.996 linear 0.031 −
anhydroecgonine methylester <MQL − − <MQL in composites and passive
disks
− −
cocaethylene 5.0 ± 2.8 − − <MQL in most composites − −
mephedrone <MQL − − <MQL in composites and passive
disks
− −
MDPV <MQL − − <MQL in composites and passive
disks
− −
opioid and metabolite heroin <MQL − − <MQL in composites and passive
disks
− −
6-acetylmorphine <MQL − − <MQL in composites and passive
disks
− −
aKey: E1, estrone; E2, 17β-estradiol; EE2, 17α-ethinylestradiol; EDDP, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; MDMA, 3,4-
methylenedioxy-methamphetamine; MDA, 3,4-methylenedioxy-amphetamine; MDPV, methylenedioxypyrovalerone.
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3. RESULTS AND DISCUSSION
3.1. Method Performance. The UPLC−MS/MS method-
ology applied achieved instrumental detection limits (IDLs)
ranging from 0.01 to 1.16 ng mL−1 for the 88 targeted
micropollutants (see Table S3).15 This corresponded to
instrument quantitation limits (IQLs) between 0.03 and 5.79
ng mL−1. These IDLs and IQLs are typical for similar
multiresidue methods reported in the literature.14,20 For further
information and discussion on the instrument performance and
its validation, please refer to Petrie et al.15 (see Table S3).
For the Chemcatchers, Atlantic HLB disks were chosen as the
receiving phase. This conﬁguration was preferred over POCIS,
which contains the equivalent mass of sorbent as a powder. This
is because loose sorbent within POCIS can sag toward the base of
the device during deployment in the vertical plane, potentially
reducing the active sampling surface area and increasing
variability in uptake rate.9 In the disks, the sorbent is
immobilized. Using disks over powder will help minimize
variability of ﬁeld data while improving ease of use. The Atlantic
HLB disks achieved recoveries ranging from 21% for creatinine
to 144% for N-desmethyltramadol. The majority of micro-
pollutants exhibited recoveries in the range of 80−110% (see
Table S3) with RSDs (n = 3), generally <20%. Spiked
environmental extracts showed matrix suppressions ranging
from −241% (signal enhancement) for atorvastatin to 96% for
creatinine (see Table S3). This level of matrix suppression is
Figure 1. Representative micropollutant uptake in passive samples (□, primary axis, n = 3) and corresponding eﬄuent wastewater concentration (○,
secondary axis, n = 3) over 9 days. For all micropollutants, see Figures S3−6.
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typical for environmental applications using HLB as a SPE
sorbent (and electrospray ionization).14,15 Method detection
limits were <17 ng disk−1 for all micropollutants, with several
reaching ≤0.01 ng disk−1. The method quantitation limits
(MQLs) achieved were in the range 0.02−55.4 ng disk−1 (see
Table S3). The majority of micropollutants exhibited MQLs < 1
ng disk−1, demonstrating the sensitivity of the methodology
applied.
3.2. Eﬄuent Concentrations and in Situ Calibration. To
ensure that accurate ﬁeld RS values could be determined, a robust
composite sampling protocol was applied. Subsample collection
frequencies of 15 min were used to ensure that representative
samples were collected. These were cooled to 4 °C until
collection and subsequent analysis to limit micropollutant
degradation were completed. For further information. please
refer to Petrie et al.19
From the 88 micropollutants studied, 66 were detected in
composite samples during the 8 day calibration study (Table 1).
Of the 66 detected compounds, 65 were found in every
composite sample. Furthermore, the majority exhibited interday
concentration variations of <20% (n = 8) except those that are
used by the human population recreationally. For example, the
illicit stimulants MDMA and MDA had interday concentration
variations of >50% due to their high weekend usage. Never-
theless, the high detection frequency and, in general, the low
concentration variation of studied micropollutants was ideal for
in situ calibration.
In passive sampler extracts, a total of 68 micropollutants were
quantiﬁed at least once. The majority of micropollutants showed
linear uptake over the 9 day study period (Figures 1 and S3−6).
RS are reported for those micropollutants exhibiting correlation
coeﬃcients of ≥0.9 with at least six data points (and were
quantiﬁable in all composite samples throughout the passive
sampler deployment). A total of 59 micropollutants satisﬁed
these criteria, with the majority being linear between 1 and 8 days
(Table 1). The broad range of micropollutants accumulated in
the Chemcatcher and the good linearity observed for deriving RS
demonstrates the potential of this passive sampler conﬁguration
for quantitative measurements.
The Chemcatcher was also shown to be very responsive to
changes in micropollutant concentration. The best example of
this is MDMA, the concentration of which in the receiving-phase
disks responded to the increased concentration found in eﬄuent
from day 6 (due to recreational usage on the weekends) (Figure
1). Due to the Chemcatcher’s responsiveness in relatively short-
term concentration changes, the RS of MDMA could be
determined with good linearity (r2 = 0.986).
Field RS values ranged from 0.011 L day
−1 for benzophenone-3
to 0.326 L day−1 for temazepam (Table 1). The majority of
micropollutants (85%) had RS values ranging from 0.01 to 0.10 L
day−1. It is diﬃcult to directly compare the RS values derived here
with those in previous studies due to diﬀerences in the passive
sampler deployed (design, exposed surfaced area. and sorbent) as
well as the matrix investigated. Furthermore, this sampler
conﬁguration using the Atlantic HLB disk has not been
previously reported. For three micropollutants (metformin,
acetaminophen, and ethylparaben), curve−linear uptake was
observed, and RS could not be determined (Figures 1, S3, and
S4). Here, equilibrium was reached within 4 days and log KPW
values were 1.94, 3.08, and 3.03, respectively (Table 1).
Metformin had the lowest log KPW due to its high hydrophilicity
(log KOW of −2.6).
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3.3. Can log KOW and log DOW Predict Micropollutant
Uptake? Ideally, if RS could be estimated from physicochemical
properties such as log KOW or log DOW, less-rigorous calibration
studies may be needed in the future.6 The majority of previous
studies have attempted to relate chemical properties with the RS
values of only a few compounds (typically <25 pesticides or
herbicides).22,23 However, Moschet et al.6 has reported a weak
linear regression (r2) of 0.37 with ﬁeld RS values (river water) of
88 micropollutants (onto styrenedivinylbenzene disks) and log
DOW values. However, no previous study has investigated the
uptake of polar micropollutants to the receiving phase used here.
In our study, it was attempted to relate the 59 ﬁeld RS values with
compound-speciﬁc physicochemical properties.
Initially, log KOW and log DOW was plotted against RS with no
relationship found. Therefore, to investigate this further, studied
micropollutants were separated into neutral, positively charged,
negatively charged, and zwitterionic species at the pH of
wastewater eﬄuent during the calibration study (pH 7.2) (see
Table S1). Field RS for each group of micropollutants were then
plotted against log KOW or log DOW to establish whether or not a
relationship exists. For neutral micropollutants (<50% ionised), a
poor linear regression was noted between RS and log KOW (r
2 =
0.11, n = 9) (see Figure S7). Linear regressions (r2) of 0.15 (n =
28), 0.02 (n = 14), and 0.93 (n = 4) were found between the log
DOW and RS values of positively charged, negatively charged and
zwitterionic micropollutants, respectively (see Figure S7).
Therefore, no clear relationship could be established using the
dominant charged states of studied micropollutants with logKOW
or log DOW for a suﬃcient number of data points. It is likely that
other interactions govern the uptake of polar micropollutants
onto the HLB sorbent, and this requires more detailed
investigation in the future.
A better understanding on the role of external factors (e.g.,
temperature and pH) onmicropollutant uptake in the ﬁeld is also
needed. These investigations would ideally be performed ex situ
using real matrix under laboratory-style conditions (e.g., see
Vermeirssen et al.).24 This approach would combine the
necessity of using the relevant environmental matrix for
representative micropollutant uptake with the advantages of
laboratory conditions, in which external factors can be closely
controlled. Investigating such factors individually may help
understand the underpinning properties or mechanisms
controlling micropollutant uptake. However, care must be
taken if this approach is to be adopted to ensure the stability of
micropollutants in the test matrix if a continuous fresh supply of
the matrix is not available for the duration of the study. Ideally,
this would lead to the development of a theoretical model to
predict RS on the basis of physicochemical properties and speciﬁc
ﬁeld conditions at the site of deployment. This would also be
aided if there was a standardized approach to passive sampling,
such that ﬁeld RS could be collated. The Chemcatcher containing
an Atlantic HLB disk provides this opportunity due to its ease of
use and suitability for a broad range of micropollutants.
3.4. Quantitative Determination of Micropollutants
Using Passive Samplers. The reliability of the calibration data
was tested by using the ﬁeld-derived RS (or KPW for
acetaminophen, ethylparaben, and metformin) to determine
the average eﬄuent concentration of the micropollutants over a 7
day trial (January 19, 2015). The use of the 7 day data point
ensured being in the linear uptake phase for the majority of
studied compounds (Figure 1). Considering the good linearity
achieved, it is unsurprising that the eﬄuent concentration
determined using passive samples and composite samples were
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similar (see Table S5). The concentration of micropollutants
measured using passive samplers was generally within ±20% of
that determined from composite samples (see Figure S8A). Only
the illicit stimulant methamphetamine showed a notable
diﬀerence of +52% between concentrations estimated by passive
and composite samples (see Table S5). However, it should be
noted that the concentrations for the majority of micropollutants
determined by the passive samplers were underestimated (52 of
62), albeit not greatly (maximum = −25%) (see Figure S8A).
This is due to a probable lag between deployment and the start of
micropollutant uptake (Figures 1 and S3−6). Therefore, despite
uptake being linear, it does not pass through the origin for all
micropollutants when RS was determined. Vermeirssen et al.
24
found that more-hydrophobic compounds had a tendency to
accumulate on the PESmembrane, resulting in a lag phase before
being found in the sorbent. A further possible explanation for this
is that the passive disks were deployed when dry. Although the
HLB sorbent is water-wettable, deploying them wet may reduce
this lag in uptake. This will be considered in future studies.
The robustness of the calibration was challenged by deploying
passive samplers (n = 7) for 7 days in June 2015 to determine
average micropollutant concentrations. Measured concentra-
tions were compared directly to those from 24 h composite
samples over the deployment period. It is assumed that the
calibration can be applied to future monitoring at the same site
where the calibration was performed and micropollutant uptake
will not diﬀer signiﬁcantly.4 However, wastewater characteristics
can change signiﬁcantly with season, which could aﬀect
micropollutant uptake. Here, measured wastewater variables
such as ﬂow and temperature were notably diﬀerent (see Table
S6). Average wastewater ﬂows were 39 774± 2492 and 24 875±
2340 m3 day−1 in January and June, respectively. Wastewater
temperatures were 8.4 ± 0.5 and 14.2 ± 0.8 °C. Such diﬀerences
are typical of conditions experienced at WwTW in the United
Kingdom between the winter and summer months. Of the other
wastewater characteristics monitored (pH, TOC, DOC, and
suspended solids), no substantial diﬀerences were observed
between the studies in January and June.
Average micropollutant concentrations measured for the 7 day
time period in June using passive samplers ranged from 3.5± 1.3
ng L−1 for ethylparaben to 37 784 ± 6435 ng L−1 for metformin
(see Table S5). A total of 60 micropollutants were quantiﬁed
using calibration data, with 55 (92%) being within a factor of 2 of
those determined in composite samples (see Figure S8B). This
included micropollutants that changed signiﬁcantly in their
concentration between the calibration and monitoring study due
to seasonal usage (e.g., the antihistamines fexofenadine and
cetirizine) (see Table S5). However, generally, the percentage
error of micropollutant concentrations determined by passive
samples versus composite samples were greater in June than in
January (when the calibration was performed) (see Table S5).
This is not unexpected considering the diﬀerent ﬁeld conditions
experienced between the two study periods. Diﬀerences in
compound uptake due to variable environmental conditions can
be adjusted by using performance reference compounds.25,26
However, they were not deemed appropriate in this study
because they require further investigation for polar compounds,
and conditions at the WwTWwere relatively constant. Despite a
lower daily ﬂow of wastewater in June (37%), this is not expected
to have had a signiﬁcant impact onmicropollutant uptake. This is
because changes to ﬂow velocity at the sampling site (deep
chamber) is considered to be low for the changes in ﬂow
observed (24 875 versus 39 774 m3 day−1). Furthermore,
previous studies have found changes in ﬂow velocity (0.1 to
0.4 m s−1) to have little impact upon ﬁeld RS in rivers.
6
The temperature diﬀerence (+ 5.8 °C) is more likely to
contribute to the greater diﬀerences observed. Studies conducted
under laboratory conditions have noted that increased water
temperature generally increased RS for test analytes.
27,28 This is
explained by a temperature increase modifying compound
solubility and log KOW, thus facilitating the transfer of
compounds from water to the sorbent.27 Consideration must
also be given to the competitive uptake of other organic
compounds. Despite DOC (mg L−1) not changing signiﬁcantly
between the January and June sampling periods (see Table S6),
the composition of this was not further characterized. Therefore,
diﬀerences in the chemical composition of wastewater, resulting
in diﬀerences in micropollutant uptake between January and
June conditions, cannot be excluded.
Micropollutants with a 2-fold concentration diﬀerence were
amphetamine, atorvastatin, azithromycin, benzophenone-3, and
ﬂuoxetine, all of which overestimated concentration, ranging
from 112 to 169% of the concentration determined in composite
samples (see Table S5). Interestingly, the relationship between
error and RS showed that these ﬁve micropollutants had relatively
low RS (≤0.032 L day−1) (see Figure S8B). It is postulated that a
lower sensitivity of uptake is subject to greater interference from
external factors (temperature and extent of biofouling), which
can change between the time of calibration (winter) and
subsequent monitoring (summer).
3.5. Passive Samplers for EF Determination of Chiral
Micropollutants. Reporting concentration of chiral micro-
pollutants at the enantiomeric level is essential for more-accurate
environmental risk assessment.1 Due to stereoselectivity within
the human body and during wastewater treatment, chiral
micropollutants do not enter the environment in the
enantiomeric form in which they are dispensed, and stereo-
selective toxicity toward aquatic biota is known to occur.11−13
This is signiﬁcant because toxicological studies are often
conducted using the dispensed form of the micropollutant
(typically as a racemic mixture), as stereoselectivity is not
considered. Therefore, further knowledge is needed on the
enantiomeric distribution of chiral micropollutants entering the
environment to inform future toxicity driven studies.
To date, passive samplers have not been investigated for
reporting the stereoselectivity of chiral micropollutants. Uptake
of enantiomers of the same chiral micropollutant onto passive
samplers will not be stereoselective in nature because it is a
physicochemical process. However, stereoselective transforma-
tion may occur on the sorbent during deployment. The stability
of micropollutants in passive samples is poorly understood due
to the diﬃculty of assessing this in the ﬁeld. Comparing the
enantiomeric distribution of chiral micropollutants extracted
from passive sampler receiving-phase disks with composite
samples will help indicate micropollutant stability.
Mean EFs of atenolol, MDMA, tramadol, and venlafaxine
determined from composite samples over 7 days were 0.48 ±
0.01, 0.28 ± 0.06, 0.53 ± 0.01, and 0.50 ± 0.02, respectively
(Table 2). In extracts from passive samplers deployed for 7 days,
EFs were 0.48 ± 0.02, 0.31 ± 0.02, 0.52 ± 0.01, and 0.49 ± 0.01,
showing no signiﬁcant diﬀerences with composite samples. This
demonstrates there were no stereoselective changes for these
micropollutants during the deployment of passive samplers.
Considering bacteria tend to be 0.2 to 2.0 μm in diameter, the
PES membrane (0.2 μm pores) should provide a physical barrier
to their transport onto the sorbent.
Environmental Science & Technology Article
DOI: 10.1021/acs.est.6b02216
Environ. Sci. Technol. 2016, 50, 9469−9478
9476
Therefore, passive samplers were successful in describing the
enantiomeric distribution of these chiral micropollutants and can
be used for the development of more accurate environmental risk
assessments. Also, improved sensitivity in passive samples
enabled the EF of MDA to be determined (EF = 0.55 ± 0.03)
(Table 2). This was not possible for composite samples using the
enantioselective CBH method due to the low background
concentrations found in ﬁnal eﬄuent.
3.6. Considerations for Implementing Passive Sam-
pling for Routine Environmental Monitoring. Implement-
ing passive sampling into routine monitoring of micropollutants
oﬀers several advantages. The approximate cost per sample
(consumable and analysis costs only) for passive and active
sampling was €33.57 and €22.12, respectively (see Table S7).
However, the total cost of consumables and analysis for the
monitoring study conducted over 7 days (June 3−9, 2015) using
24 h composite samples was €464.52 (n = 21, triplicate analysis).
In comparison, passive sampling was ∼50% cheaper at a cost of
€234.99 (n = 7). This is due to the higher number of samples
required for active sampling for a 7 day monitoring period. Yet
the diﬀerence in cost between the sampling modes will be greater
considering the number of site visits required. Each site visit here
cost approximately €10.32 (24 km traveled at €0.43 per km).
Passive sampling only required two site visits for the 7 day study,
one for deployment and one for collection. This was suitable for
wastewater eﬄuent because little fouling occurred on the surface
of the samplers during deployment. In contrast, 7 day composite
sampling required a total of eight site visits (one for deployment
and seven for collection). The number of site visits could not be
reduced due to the poor stability of micropollutants in collected
wastewater at 4 °C for >24 h.19 Hence, the total ﬁnancial savings
by applying passive sampling over composite sampling will be
dependent on the proximity of the sampling site to the analysis
laboratory. In this study, the total cost of monitoring wastewater
eﬄuent for a 7 day period was €255.63 for passive sampling and
€547.19 for active sampling (excluding labor costs). Further
savings can also be made if passive samplers are deployed for
longer time periods. Samplers for quantitative analysis have been
previously deployed in the ﬁeld for up to 14 days.3,4,6
Passive sampling also avoids problems associated with
composite samplers, which can malfunction despite daily
maintenance, resulting in the loss of sample continuity.19 Passive
samplers can also fail (e.g., due to membrane breakage) but
replicates are deployed, which helps overcome this issue.
Furthermore, several micropollutants (benzophenone-1, dihy-
dromorphine, and ketamine) were detected in passive samples
that were not found in their corresponding composite samples
(Table 1). This improved sensitivity demonstrates their possible
application as a qualitative tool for nontargeted screening and
identifying of unknown compounds. However, passive sampling
does have some limitations. For example, it cannot achieve the
resolution of daily sampling, and acute variability in micro-
pollutant concentration (e.g., from recreational use or direct
disposal)29 will not be fully appreciated during a weekly sampling
campaign. A further disadvantage of passive sampling, partic-
ularly with in situ calibration observed during this study, is
associated with temporal changes in micropollutant occurrence.
For example, a calibration could not be established for
benzophenone-1 and ketamine due to their concentration in
composite samples being <MQL in January, 2015 (<0.71 and
<0.93 ng L−1, respectively). However, in the monitoring study
(June, 2015), they were found at concentrations of 60.1 ± 20.4
and 4.1 ± 1.5 ng L−1, respectively, in composite samples but
could not be quantiﬁed using passive samples because the RS was
unknown (see Table S5). Nevertheless, in situ calibration of
passive samplers has shown to be very promising for the
quantitative determination of micropollutants in wastewater
eﬄuent. However, their application in a legislative context will
require further understanding of the physicochemical properties
controlling micropollutant uptake and the inﬂuence of external
factors experienced in the ﬁeld during monitoring studies (e.g.,
temperature). This will help improve the accuracy of micro-
pollutant concentrations reported by passive sampling. There-
fore, in the short term, it is expected that future monitoring
studies using passive samplers (previously calibrated in situ) will
need to be supported with some active sampling to help validate
ﬁndings.
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